ReviewJournal of clinical medicine2026

Therapeutic Drug Monitoring of the Subcutaneous Formulations of Infliximab and Vedolizumab-Current Knowledge and Future Directions.

Ben Massouridis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.